Search

everythinglearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The document explains various skin conditions and their treatments.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.